Tango Therapeutics TNGX
NASDAQ TNGX
$24.45 -0.50 (-2.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Change in Receivables (2023)

Updated

Tango Therapeutics' Change in Receivables was -$2 million in FY2023.

Analysis

Tango Therapeutics (TNGX) Change in Receivables (2023) Analysis & Trends

  • The FY2023 figure marks the highest annual Change in Receivables since FY2020.
  • Per Business Quant data, Change in Receivables in earlier years was $2 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Tango Therapeutics 4.20 Bn 2.31 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -2.00 Mn
API Access

Tango Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TNGX&period=max&api_key=YOUR_API_KEY